62 related articles for article (PubMed ID: 19320733)
21. MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma.
Zhao X; Zhang W; Ji W
Onco Targets Ther; 2018; 11():3619-3635. PubMed ID: 29950866
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan.
Sheen YS; Liao YH; Lin MH; Chen JS; Liau JY; Liang CW; Chang YL; Chu CY
PLoS One; 2017; 12(5):e0177126. PubMed ID: 28472158
[TBL] [Abstract][Full Text] [Related]
23. Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin.
Hernando B; Ibarrola-Villava M; Fernandez LP; Peña-Chilet M; Llorca-Cardeñosa M; Oltra SS; Alonso S; Boyano MD; Martinez-Cadenas C; Ribas G
Biol Sex Differ; 2016; 7():17. PubMed ID: 26998216
[TBL] [Abstract][Full Text] [Related]
24. Pigmentary Markers in Danes--Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.
Johansen P; Andersen JD; Madsen LN; Ullum H; Glud M; Børsting C; Gniadecki R; Morling N
PLoS One; 2016; 11(3):e0150381. PubMed ID: 26938746
[TBL] [Abstract][Full Text] [Related]
25. Update in genetic susceptibility in melanoma.
Potrony M; Badenas C; Aguilera P; Puig-Butille JA; Carrera C; Malvehy J; Puig S
Ann Transl Med; 2015 Sep; 3(15):210. PubMed ID: 26488006
[TBL] [Abstract][Full Text] [Related]
26. Admixture mapping identifies a locus at 15q21.2-22.3 associated with keloid formation in African Americans.
Velez Edwards DR; Tsosie KS; Williams SM; Edwards TL; Russell SB
Hum Genet; 2014 Dec; 133(12):1513-23. PubMed ID: 25280642
[TBL] [Abstract][Full Text] [Related]
27. Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis.
Ouderkirk JL; Krendel M
Cytoskeleton (Hoboken); 2014 Aug; 71(8):447-63. PubMed ID: 25087729
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans.
Zhang M; Song F; Liang L; Nan H; Zhang J; Liu H; Wang LE; Wei Q; Lee JE; Amos CI; Kraft P; Qureshi AA; Han J
Hum Mol Genet; 2013 Jul; 22(14):2948-59. PubMed ID: 23548203
[TBL] [Abstract][Full Text] [Related]
29. Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties.
Liu Y; Devescovi V; Chen S; Nardini C
BMC Syst Biol; 2013 Feb; 7():14. PubMed ID: 23418673
[TBL] [Abstract][Full Text] [Related]
30. Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.
Hawkes JE; Cassidy PB; Manga P; Boissy RE; Goldgar D; Cannon-Albright L; Florell SR; Leachman SA
J Dermatol Sci; 2013 Jan; 69(1):30-7. PubMed ID: 23103111
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.
Serão NV; Delfino KR; Southey BR; Beever JE; Rodriguez-Zas SL
BMC Med Genomics; 2011 Jun; 4():49. PubMed ID: 21649900
[TBL] [Abstract][Full Text] [Related]
32. A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene.
Ibarrola-Villava M; Fernandez LP; Alonso S; Boyano MD; Peña-Chilet M; Pita G; Aviles JA; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Izagirre N; De la Rua C; Asumendi A; Perez-Yarza G; Arroyo-Berdugo Y; Boldo E; Lozoya R; Torrijos-Aguilar A; Pitarch A; Pitarch G; Sanchez-Motilla JM; Valcuende-Cavero F; Tomas-Cabedo G; Perez-Pastor G; Diaz-Perez JL; Gardeazabal J; Martinez de Lizarduy I; Sanchez-Diez A; Valdes C; Pizarro A; Casado M; Carretero G; Botella-Estrada R; Nagore E; Lazaro P; Lluch A; Benitez J; Martinez-Cadenas C; Ribas G
PLoS One; 2011 Apr; 6(4):e19271. PubMed ID: 21559390
[TBL] [Abstract][Full Text] [Related]
33. ASIP genetic variants and the number of non-melanoma skin cancers.
Lin W; Qureshi AA; Kraft P; Nan H; Guo Q; Hu FB; Jensen MK; Han J
Cancer Causes Control; 2011 Mar; 22(3):495-501. PubMed ID: 21221757
[TBL] [Abstract][Full Text] [Related]
34. A role for ATF2 in regulating MITF and melanoma development.
Shah M; Bhoumik A; Goel V; Dewing A; Breitwieser W; Kluger H; Krajewski S; Krajewska M; Dehart J; Lau E; Kallenberg DM; Jeong H; Eroshkin A; Bennett DC; Chin L; Bosenberg M; Jones N; Ronai ZA
PLoS Genet; 2010 Dec; 6(12):e1001258. PubMed ID: 21203491
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis.
Gerstenblith MR; Shi J; Landi MT
Pigment Cell Melanoma Res; 2010 Oct; 23(5):587-606. PubMed ID: 20546537
[TBL] [Abstract][Full Text] [Related]
36. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
37. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma.
Duffy DL; Zhao ZZ; Sturm RA; Hayward NK; Martin NG; Montgomery GW
J Invest Dermatol; 2010 Feb; 130(2):520-8. PubMed ID: 19710684
[TBL] [Abstract][Full Text] [Related]
38. Pigmentation-related genes and their implication in malignant melanoma susceptibility.
Fernandez LP; Milne RL; Pita G; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
Exp Dermatol; 2009 Jul; 18(7):634-42. PubMed ID: 19320733
[TBL] [Abstract][Full Text] [Related]
39. SLC45A2: a novel malignant melanoma-associated gene.
Fernandez LP; Milne RL; Pita G; Avilés JA; Lázaro P; Benítez J; Ribas G
Hum Mutat; 2008 Sep; 29(9):1161-7. PubMed ID: 18563784
[TBL] [Abstract][Full Text] [Related]
40. Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.
Jannot AS; Meziani R; Bertrand G; Gérard B; Descamps V; Archimbaud A; Picard C; Ollivaud L; Basset-Seguin N; Kerob D; Lanternier G; Lebbe C; Saiag P; Crickx B; Clerget-Darpoux F; Grandchamp B; Soufir N; Melan-Cohort
Eur J Hum Genet; 2005 Aug; 13(8):913-20. PubMed ID: 15889046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
